MARATTO

article · World Journal of Advanced Research and Reviews

Chikungunya Virus serological cross-reactivity in co-endemic settings: Mechanisms, Diagnostic implications, and epidemiological consequences

Abstract

Chikungunya virus (CHIKV) causes an acute febrile illness with debilitating arthralgia, and serological assays remain central to its diagnosis and surveillance. However, antibody-based results are complicated by cross-reactivity in settings where multiple arboviruses co-circulate. This review distinguishes three related but distinct phenomena affecting CHIKV serology: biological cross-reactivity, arising from genuine antigenic overlap between related viruses; assay-associated non-target reactivity, in which a diagnostic platform generates a positive signal without an established biological relationship between the viruses; and diagnostic misclassification, the downstream epidemiological consequence of conflating the two. Applying this framework to five virus pairs, we find that CHIKV–O'nyong-nyong virus (ONNV), CHIKV–Mayaro virus (MAYV) and CHIKV–Ross River virus (RRV) relationships are supported by shared alphavirus antigenic architecture and, in several studies, by functional cross-neutralisation. By contrast, CHIKV reactivity reported in dengue virus (DENV)- and Zika virus (ZIKV)-associated sera lacks an established biological basis and is better classified as assay-associated non-target reactivity of unresolved mechanism. These distinctions matter: unadjusted seropositivity can inflate or obscure CHIKV transmission estimates, and no single diagnostic platform resolves the problem for every virus pair. We argue that CHIKV diagnosis in co-endemic settings requires a layered strategy: molecular detection during the acute phase, antigenically informed and multiplex serology thereafter, and neutralisation-based confirmation where attribution is critical, combined with cross-reactivity-aware statistical modelling for surveillance. Strengthening assay validation and confirmatory testing, particularly in African settings such as Nigeria where CHIKV, DENV and related alphaviruses circulate together, is essential for improving diagnostic accuracy and epidemiological inference.

Research topics

  • Mosquito-borne diseases and control
  • Viral Infections and Outbreaks Research
  • Viral Infections and Vectors

Sustainable Development Goals

Read the original research

This page summarises published work. The authoritative version sits with the publisher.

DOI: 10.30574/wjarr.2026.31.2.2014

Is something wrong with this record? Report it or request removal.

Discussion

Discuss this research

Have you built on this work, tried to replicate it, or seen it applied in practice? Share what you know. Verified researchers and MARATTO™ domain experts can open a discussion, and any member can reply. Contributions are reviewed before they appear.

No discussion yet. Open the first thread.